Home > Research > Publications & Outputs > Not Particularly Special

Electronic data

  • NPS accepted pre-proof version

    Rights statement: This is an Accepted Manuscript of an article published by Taylor & Francis in Drugs: Education, Prevention and Policy on 12/12/2017, available online: http://www.tandfonline.com/10.1080/09687637.2017.1411885

    Accepted author manuscript, 0.99 MB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

Not Particularly Special: critiquing ‘NPS’ as a category of drugs

Research output: Contribution to journalJournal article

Published

Standard

Not Particularly Special : critiquing ‘NPS’ as a category of drugs. / Potter, Gary Richard; Chatwin, Caroline.

In: Drugs: Education, Prevention, and Policy , Vol. 25, No. 4, 2018, p. 329-336.

Research output: Contribution to journalJournal article

Harvard

Potter, GR & Chatwin, C 2018, 'Not Particularly Special: critiquing ‘NPS’ as a category of drugs', Drugs: Education, Prevention, and Policy , vol. 25, no. 4, pp. 329-336. https://doi.org/10.1080/09687637.2017.1411885

APA

Potter, G. R., & Chatwin, C. (2018). Not Particularly Special: critiquing ‘NPS’ as a category of drugs. Drugs: Education, Prevention, and Policy , 25(4), 329-336. https://doi.org/10.1080/09687637.2017.1411885

Vancouver

Author

Potter, Gary Richard ; Chatwin, Caroline. / Not Particularly Special : critiquing ‘NPS’ as a category of drugs. In: Drugs: Education, Prevention, and Policy . 2018 ; Vol. 25, No. 4. pp. 329-336.

Bibtex

@article{2530c55703ce4c1e8b73be4881fae305,
title = "Not Particularly Special: critiquing {\textquoteleft}NPS{\textquoteright} as a category of drugs",
abstract = "Novel Psychoactive Substances (NPS) have been a dominant feature of drug discourse for many years now and, in academic, policy and public discourse, have become established as a new – and by implication, distinct – category of drugs. We argue that this understanding of NPS is fundamentally problematic. Differences within the category are obscured, as are similarities between NPS and more established categories of drugs. Focusing on NPS as something new, different or particularly special is misleading and counterproductive and can have serious consequences in terms of understanding the bigger picture in relation to illegal drugs more generally. This has led to overestimations of the size of the NPS problem, obfuscation of the common underlying causes of dependent drug use, and the implementation of significant and problematic policy changes. Further, a failure to see the rise in NPS as just one of a number of emerging trends in contemporary drug scenes, alongside the development of online markets or the rise in domestic drug production operations, for example, impairs our ability to understand the wider societal, cultural and theoretical underpinnings of drug use. NPS are not particularly special: treating them as such can have dangerous and far-reaching consequences.",
keywords = "Novel psychoactive substances, drugs, drug policy",
author = "Potter, {Gary Richard} and Caroline Chatwin",
year = "2018",
doi = "10.1080/09687637.2017.1411885",
language = "English",
volume = "25",
pages = "329--336",
journal = "Drugs: Education, Prevention, and Policy ",
issn = "0968-7637",
publisher = "Informa Healthcare",
number = "4",

}

RIS

TY - JOUR

T1 - Not Particularly Special

T2 - critiquing ‘NPS’ as a category of drugs

AU - Potter, Gary Richard

AU - Chatwin, Caroline

PY - 2018

Y1 - 2018

N2 - Novel Psychoactive Substances (NPS) have been a dominant feature of drug discourse for many years now and, in academic, policy and public discourse, have become established as a new – and by implication, distinct – category of drugs. We argue that this understanding of NPS is fundamentally problematic. Differences within the category are obscured, as are similarities between NPS and more established categories of drugs. Focusing on NPS as something new, different or particularly special is misleading and counterproductive and can have serious consequences in terms of understanding the bigger picture in relation to illegal drugs more generally. This has led to overestimations of the size of the NPS problem, obfuscation of the common underlying causes of dependent drug use, and the implementation of significant and problematic policy changes. Further, a failure to see the rise in NPS as just one of a number of emerging trends in contemporary drug scenes, alongside the development of online markets or the rise in domestic drug production operations, for example, impairs our ability to understand the wider societal, cultural and theoretical underpinnings of drug use. NPS are not particularly special: treating them as such can have dangerous and far-reaching consequences.

AB - Novel Psychoactive Substances (NPS) have been a dominant feature of drug discourse for many years now and, in academic, policy and public discourse, have become established as a new – and by implication, distinct – category of drugs. We argue that this understanding of NPS is fundamentally problematic. Differences within the category are obscured, as are similarities between NPS and more established categories of drugs. Focusing on NPS as something new, different or particularly special is misleading and counterproductive and can have serious consequences in terms of understanding the bigger picture in relation to illegal drugs more generally. This has led to overestimations of the size of the NPS problem, obfuscation of the common underlying causes of dependent drug use, and the implementation of significant and problematic policy changes. Further, a failure to see the rise in NPS as just one of a number of emerging trends in contemporary drug scenes, alongside the development of online markets or the rise in domestic drug production operations, for example, impairs our ability to understand the wider societal, cultural and theoretical underpinnings of drug use. NPS are not particularly special: treating them as such can have dangerous and far-reaching consequences.

KW - Novel psychoactive substances

KW - drugs

KW - drug policy

U2 - 10.1080/09687637.2017.1411885

DO - 10.1080/09687637.2017.1411885

M3 - Journal article

VL - 25

SP - 329

EP - 336

JO - Drugs: Education, Prevention, and Policy

JF - Drugs: Education, Prevention, and Policy

SN - 0968-7637

IS - 4

ER -